70 related articles for article (PubMed ID: 8907632)
21. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
[TBL] [Abstract][Full Text] [Related]
22. Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF.
Bellucci R; De Propris MS; Buccisano F; Lisci A; Leone G; Tabilio A; de Fabritiis P
Bone Marrow Transplant; 1999 Jan; 23(1):1-8. PubMed ID: 10037043
[TBL] [Abstract][Full Text] [Related]
23. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses.
Murea S; Goldschmidt H; Hahn U; Pförsich M; Moos M; Haas R
J Clin Apher; 1996; 11(4):185-94. PubMed ID: 8986864
[TBL] [Abstract][Full Text] [Related]
24. Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.
Shapiro F; Yao TJ; Moskowitz C; Reich L; Wuest DL; Heimfeld S; McNiece IK; Gabrilove J; Nimer S; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1571-8. PubMed ID: 9815845
[TBL] [Abstract][Full Text] [Related]
25. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
[TBL] [Abstract][Full Text] [Related]
26. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
27. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
[TBL] [Abstract][Full Text] [Related]
29. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
30. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
31. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
[TBL] [Abstract][Full Text] [Related]
32. Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens.
Cesana C; Regazzi E; Garau D; Caramatti C; Mangoni L; Rizzoli V
Haematologica; 1999 Sep; 84(9):771-8. PubMed ID: 10477448
[TBL] [Abstract][Full Text] [Related]
33. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
[TBL] [Abstract][Full Text] [Related]
34. Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells.
Di Nicola M; Siena S; Bregni M; Ravagnani F; Vitello F; Belli N; Dodero A; Magni M; Bonadonna G; Gianni AM
Bone Marrow Transplant; 1994 Dec; 14(6):863-9. PubMed ID: 7536068
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood.
Roecklein BA; Reems J; Rowley S; Torok-Storb B
Biol Blood Marrow Transplant; 1998; 4(2):61-8. PubMed ID: 9763108
[TBL] [Abstract][Full Text] [Related]
36. Direct isolation and expansion of human CD34+ hematopoietic stem cells.
Lebkowski J; Schain L; Harvey M; Moseley A; Okarma TB
J Hematother; 1993; 2(3):339-42. PubMed ID: 7522888
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo expansion of hematopoietic progenitors from CD34+ cells selected from leukapheresis products of lymphoma and myeloma patients: feasibility and enhancement by fibronectin.
Mahé B; Pineau D; Robillard N; Accard F; Hermouet S
J Hematother; 1996 Dec; 5(6):671-9. PubMed ID: 9117256
[TBL] [Abstract][Full Text] [Related]
38. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma.
Gorin NC; Lopez M; Laporte JP; Quittet P; Lesage S; Lemoine F; Berenson RJ; Isnard F; Grande M; Stachowiak J
Blood; 1995 Mar; 85(6):1647-54. PubMed ID: 7534139
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo expansion of human peripheral blood progenitors.
Chabannon C; Herrera-Rodriguez D; Bardin F; Mouren M; Novakovitch G; Blaise D; Maraninchi D; Mannoni P
Nouv Rev Fr Hematol (1978); 1995; 37(6):351-8. PubMed ID: 8907631
[TBL] [Abstract][Full Text] [Related]
40. The purification of CD34 cells from human cord blood: comparison of separation techniques and cytokine requirements for optimal growth of clonogenic progenitors.
Charbord P; Newton I; Voillat L; Schaal JP; Herve P
Br J Haematol; 1996 Sep; 94(3):449-54. PubMed ID: 8790140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
